Last reviewed · How we verify

NCT05368714

Suubi4StrongerFamilies

Active, enrolled NA Last updated 13 January 2026
What this trial tests

NA trial testing Economic Empowerment (EE) in Child Behavioral Health in 967 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 June 2022
Primary endpoint
1 March 2027
1 April 2027

Quick facts

Lead sponsorWashington University School of Medicine
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment967
Start date14 June 2022
Primary completion1 March 2027
Estimated completion1 April 2027
Sites1 location across Uganda

Drugs / interventions tested

Conditions studied

Sponsor

Washington University School of Medicine

Who can join

Adults 10 to 14, any sex, with Child Behavioral Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will examine the mechanisms by which Economic Empowerment (EE) and Family Strengthening (FS) interventions targeting social, familial and context-specific drivers affect childhood behavioral health (CBH). The study will randomly assign 900 children in mid-upper primary school (10 to 14 years) to one of the three study arms (10 schools each): 1) EE only (n=300), 2) Multiple Family Group (MFG)-based FS only (n=300), and 3) combined EE+MFG-based FS (n=300). The interventions will be provided for 12 months. Assessments will occur at baseline, 12, 24 and 36 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Washington University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05368714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing